Mass Spectrometry Market Report 2025

The mass spectrometry market size has grown strongly in recent years. It will grow from $6.65 billion in 2024 to $7.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to regulatory compliance, increased research and development investments, increased pharmaceutical and biotechnology demand, environmental monitoring, clinical diagnostics have shaped historical growth.

The mass spectrometry market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing healthcare expenditure, expanding applications in food safety, emerging markets adoption, advancements in precision medicine, cross-industry collaborations. Major trends in the forecast period include advances in ionization techniques, growing role in food and beverage testing, collaboration for multi-omics research, enhanced data accessibility and cloud-based solutions.

The anticipated rise in chronic diseases is set to drive the growth of the mass spectrometry market in the future. Chronic diseases, lasting for three months or longer and worsening over time, are prevalent globally. Mass spectrometry techniques play a crucial role in identifying, quantifying, and analyzing biomarkers and metabolites associated with chronic diseases. According to the World Health Organization, non-communicable diseases (NCDs) or chronic diseases account for 74% of the 41 million annual deaths worldwide. The increasing prevalence of cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes underscores the importance of mass spectrometry in disease analysis. Furthermore, a report from the National Institutes of Health (NIH) predicts a 99.5% increase in the number of people aged 50 and older with at least one chronic illness, from 71.522 million in 2020 to 142.66 million in 2050. Hence, the mass spectrometry market is witnessing growth due to the escalating prevalence of chronic diseases.

The expansion of the beverage industry is expected to contribute to the growth of the mass spectrometry market. The beverage industry involves the production, distribution, and sale of liquid refreshments. Mass spectrometry is employed for precise analysis and characterization of compounds, ensuring quality control, flavor profiling, and identification of contaminants in beverages. In the United States, the beverage industry is valued at $146 billion and is projected to experience an annual growth rate of 1.7% by 2027, according to BlueCart. Therefore, the growing beverage industry is a driving factor for the mass spectrometry market.

Product innovation stands out as a prominent trend in the mass spectrometry market. Leading companies in the market are dedicated to developing innovative products with advanced features to fortify their market positions. For example, Agilent Technologies Inc., a U.S.-based company, launched LC/MS and GC/MS quadrupole mass spectrometers in June 2022. The Agilent 6475 triple quadrupole LC/MS system is characterized by sensitivity, robustness, and ruggedness. Major features include a unique superheated Agilent Jet Stream (AJS) ion source, curved and tapered collision cell, ± 20 kV high-energy dynode detector system, and heated hyperbolic quadrupoles. Additionally, the system offers early maintenance feedback, intelligent secondary injection workflows, and scheduled tune and check-tune.

Major companies in the mass spectrometry market are prioritizing the development of advanced mass spectrometers to gain a competitive edge. The Astral analyzer, a state-of-the-art mass spectrometer known for its fast throughput, high sensitivity, and deep proteome coverage, is one such example. Thermo Fisher, a U.S.-based supplier of analytical instruments, launched the Orbitrap Astral mass spectrometer in June 2023. This groundbreaking technology allows researchers to efficiently discover previously undetected proteins, aiding in the identification of new clinical biomarkers and early disease detection. The Orbitrap Astral builds on Thermo Fisher's Orbitrap mass spectrometry platform, providing up to two times deeper proteome coverage and up to four times more throughput than current spectrometers.

In July 2022, Inotiv Inc., a U.S.-based medical research organization specializing in non-clinical and analytical methods for drug discovery and development, acquired Protypia, Inc. for an undisclosed amount. This strategic acquisition enhances Inotiv's bioanalytical capabilities and allows prospective consumers to translate clinical findings back into their discovery and preclinical pipelines. Protypia Inc., a U.S.-based proteomics bioanalytical company, operates in the mass spectrometry market.

Major companies operating in the mass spectrometry market include Agilent Technologies Inc., Bruker Corporation, JEOL Ltd., LECO Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, AB Sciex Pte Ltd., Danaher Corporation, Hitachi Ltd., Rigaku Corporation, Advion Inc., AMETEK. Inc., Analytik Jena GmbH, DANI Instruments S.p.A., Eurofins Scientific SE, FLIR Systems Inc., MKS Instruments, Elementar Analysensysteme GmbH, Hiden Analytical Europe GmbH, SPECTRO Analytical Instruments GmbH, EXUM INSTRUMENTS INC., 908 Devices Inc., MassTech Inc., Newomics Inc., Microsaic Systems plc, SCIEX AB, Kore Technologies Ltd., IonSense Inc.

North America was the largest region in the mass spectrometry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the mass spectrometry market size forecast period. The regions covered in the mass spectrometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mass spectrometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mass spectrometry is an analytical technique utilized for the identification and quantification of molecules based on their mass-to-charge ratio. The process involves ionizing a sample, separating the resulting ions according to their mass-to-charge ratio, and then detecting them to generate a mass spectrum.

The main technologies employed in mass spectrometry include hybrid mass spectrometry, single mass spectrometry, and inductively coupled plasma mass spectrometry (ICP-MS). Hybrid mass spectrometry combines multiple mass spectrometry techniques to enhance analytical capabilities and improve molecular characterization. This technology finds applications in various fields, including life science research, drug discovery, environmental testing, food testing, applied industries, and clinical diagnostics. Industries and sectors utilizing mass spectrometry include the pharmaceutical and biotechnology industries, research and academic institutes, environmental testing industry, food and beverage testing industry, petrochemical industry, and others.

The mass spectrometry market research report is one of a series of new reports that provides mass spectrometry market statistics, including the mass spectrometry industry global market size, regional shares, competitors with a mass spectrometry market share, detailed mass spectrometry market segments, market trends, and opportunities, and any further data you may need to thrive in the mass spectrometry industry. This mass spectrometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mass spectrometry market consists of revenues earned by entities by providing services such as analytical testing, proteomics analysis, metabolomics studies, drug discovery support, environmental analysis, and forensic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The mass spectrometry market also includes sales of mass spectrometers, ionization sources, and detectors, which are used in providing mass spectrometry services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.